<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/HIV_Support.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:19 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1031006">
<meta name="Category" content="Concern">
<meta name="Article" content="HIV_Support">
<title>Asistencia para Enfermos con VIH y SIDA-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Asistencia para Enfermos con VIH y SIDA</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="HIV_Support.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">The Group for the Scientific Reappraisal of the HIV/AIDS Hypothesis. AIDS
Proposal. <em>Science</em> 1995;267:945&#8211;6.</li>

<li class="Ref">Duesberg PH. <em>Inventing the AIDS Virus</em>. Washington, DC: Regnery
Publishing, Inc., 1996.</li>

<li class="Ref">Maggiore C, Mullis K. <em>What if everything you thought you knew about AIDS
was wrong?</em> Studio City, CA: American Foundation for AIDS Alternatives, 2000.</li>

<li class="Ref">Gibert CL, Wheeler DA, Collins G, et al. Randomized, controlled trial of
caloric supplements in HIV infection. <em>J Acquir Immune Defic Syndr</em>
1999;22:253&#8211;9</li>

<li class="Ref">Nellen H, Flores G, Wacher N. Treatment of human immunodeficiency virus
enteropathy with a gluten-free diet. <em>Arch Intern Med</em> 2000;160:244 [letter].</li>

<li class="Ref">Roubenoff R, McDermott A, Weiss L, et al. Short-term progressive resistance
training increases strength and lean body mass in adults infected with human immunodeficiency
virus. <em>AIDS</em> 1999;13:231&#8211;9.</li>

<li class="Ref">Mustafa T, Sy FS, Macera CA, et al. Association between exercise and HIV
disease progression in a cohort of homosexual men. <em>Ann Epidemiol</em>
1999;9:127&#8211;31.</li>

<li class="Ref">Ince S. Vitamin supplements may help delay onset of AIDS. <em>Med Tribune</em>
1993;9:18.</li>

<li class="Ref">Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements
in relation to vertical transmission of HIV-1 in Tanzania. <em>J Acquir Immune Defic
Syndr</em> 2000;23:246&#8211;54.</li>

<li class="Ref">Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is
associated with selenium deficiency. <em>J Acquir Immune Defic Syndr Hum Retrovirol</em>
1997;15:370&#8211;4.</li>

<li class="Ref">Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J. Selenium supplementation of
symptomatic human immunodeficiency virus infected patients. <em>Biol Trace Elem Res</em>
1989;25:89&#8211;96.</li>

<li class="Ref">Chariot P, Perchet H, Monnet I. Dilated cardiomyopathy in HIV-infected
patients [letter; comment]. <em>N Engl J Med</em> 1999;340:732 (discussion 733&#8211;5).</li>

<li class="Ref">Zazzo JF, Lafont A, Darwiche E, et al. Is non-obstructive myocardiopathy
(NOMC) in AIDS selenium-deficiency related? In: Neve J, Favier A, eds. <em>Selenium in biology
and medicine</em>. W. DeGruyter &amp; Co.: Berlin New York, 1988, 281&#8211;2.</li>

<li class="Ref">Roederer M, Staal FJ, Raju PA, et al. Cytokine-stimulated human
immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. <em>Proc Natl Acad
Sci</em> 1990;87:4884&#8211;8.</li>

<li class="Ref">Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is
associated with impaired survival in HIV disease. <em>Proc Natl Acad Sci</em>
1997;94:1967&#8211;72.</li>

<li class="Ref">Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired
immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine,
and arginine: a randomized, double-blind, placebo-controlled study. <em>JPEN J Parenter
Enteral Nutr</em> 2000;24:133&#8211;9.</li>

<li class="Ref">Blehaut H, Saint-Marc T, Touraine J. Double blind trial of <em>Saccharomyces
boulardii</em> in AIDS-related diarrhea. International Conference on AIDS/Third STD World
Congress, 1992, Abstract #2120, July 19&#8211;24.</li>

<li class="Ref">Eng RHK, Drehmel R, Smith SM, Goldstein EJC. Saccharomyces cerevisiae
infection in man. Sabouraudia: <em>J Med Vet Mycol</em> 1984;22:403&#8211;7.</li>

<li class="Ref">Bassetti S, Frei R, Zimmerli W. Fungemia with Saccharomyces cerevisiae after
treatment with Saccharomyces boulardii. <em>Am J Med</em> 1998;105:71&#8211;2.</li>

<li class="Ref">Ferrando SJ, Rabkin JG, Poretsky L. Dehydroepiandrosterone sulfate (DHEAS) and
testosterone: relation to HIV illness stage and progression over one year. <em>J Acquir Immune
Defic Syndr</em> 1999;22:146&#8211;54.</li>

<li class="Ref">Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV +
patients: effects on mood, androgenic and anabolic parameters. <em>
Psychoneuroendocrinology</em> 2000;25:53&#8211;68.</li>

<li class="Ref">Semba RD, Graham NMH, Caiaffa WT, et al. Increased mortality associated with
vitamin A deficiency during human immunodeficiency virus type 1 infection. <em>Arch Intern
Med</em> 1993;153:2149&#8211;54.</li>

<li class="Ref">Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and
mother-to-child transmission of HIV-1. <em>Lancet</em> 1994;343:1593&#8211;7.</li>

<li class="Ref">Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect
of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1
transmission in Durban, South Africa. South African Vitamin A Study Group. <em>AIDS</em>
1999;13:1517&#8211;24.</li>

<li class="Ref">Kennedy CM, Coutsoudis A, Kuhn L, et al. Randomized controlled trial assessing
the effect of vitamin A supplementation on maternal morbidity during pregnancy and postpartum
among HIV-infected women. <em>J Acquir Immune Defic Syndr</em> 2000;24:37&#8211;44.</li>

<li class="Ref">Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements
in relation to vertical transmission of HIV-1 in Tanzania. <em>J Acquir Immune Defic
Syndr</em> 2000;23:246&#8211;54.</li>

<li class="Ref">Coutsoudis A, Bobat RA, Coovadia HM, et al. The effects of vitamin A
supplementation on the morbidity of children born to HIV-infected women. <em>Am J Public
Health</em> 1995;85:1076&#8211;81.</li>

<li class="Ref">Hanekom WA, Yogev R, Heald LM, et al. Effect of vitamin A therapy on serologic
responses and viral load changes after influenza vaccination in children infected with the
human immunodeficiency virus. <em>J Pediatr</em> 2000;136:550&#8211;2.</li>

<li class="Ref">Humphrey JH, Quinn T, Fine D, et al. Short-term effects of large-dose vitamin
A supplementation on viral load and immune response in HIV-infected women. <em>J Acquir Immune
Defic Syndr Hum Retrovirol</em> 1999;20:44&#8211;51<em>.</em></li>

<li class="Ref">Sappey C, Leclercq P, Coudray C, et al. Vitamin, trace element and peroxide
status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene
deficiency. <em>Clin Chim Acta</em> 1994;230:35&#8211;42.</li>

<li class="Ref">Coodley GO, Nelson HD, Loveless MO, Folk C. Beta-carotene in HIV infection.
<em>J Acquir Immune Defic Syndr</em> 1993;6:272&#8211;6.</li>

<li class="Ref">Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an
extended evaluation. <em>AIDS</em> 1996;10:967&#8211;73.</li>

<li class="Ref">Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental vitamin B and
progression to AIDS and death in black South African patients infected with HIV. <em>J Acquir
Immune Defic Syndr</em> 1999;21:252&#8211;3 [letter].</li>

<li class="Ref">Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS.
<em>Lancet</em> 1991;338:1086.</li>

<li class="Ref">Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6
status with parameters of immune function in early HIV-1 infection. <em>J Acquir Immune Defic
Syndr</em> 1991;4:1122&#8211;32.</li>

<li class="Ref">Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in
human immunodeficiency type 1 infection. <em>Am J Epidemiol</em> 1996;143:1244&#8211;56.</li>

<li class="Ref">Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection. <em>
Lancet</em> 1990;335:1401&#8211;2.</li>

<li class="Ref">Murray MF. Niacin as a potential AIDS preventive factor. <em>Med
Hypotheses</em> 1999;53:375&#8211;9.</li>

<li class="Ref">Murray MF, Srinivasan A. Nicotinamide inhibits HIV-1 in both acute and chronic
in vitro infection. <em>Biochem Biophys Res Commun</em> 1995;210:954&#8211;9.</li>

<li class="Ref">Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in
human immunodeficiency type 1 infection. <em>Am J Epidemiol</em> 1996;143:1244&#8211;56.</li>

<li class="Ref">Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human
immunodeficiency type 1 infection. <em>Am J Epidemiol</em> 1996;143:1244&#8211;56.</li>

<li class="Ref">Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency
virus replication by ascorbate in chronically and acutely infected cells. <em>Proc Natl Acad
Sci</em> 1990;87:7245&#8211;9.</li>

<li class="Ref">Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in
human immunodeficiency type 1 infection. <em>Am J Epidemiol</em> 1996;143:1244&#8211;56.</li>

<li class="Ref">Cathcart RF III. Vitamin C in the treatment of acquired immune deficiency
syndrome (AIDS). <em>Med Hypotheses</em> 1984;14:423&#8211;33.</li>

<li class="Ref">Gogu SR, Beckman BS, Rangan SR, Agrawal KC. Increased therapeutic efficacy of
zidovudine in combination with vitamin E. <em>Biochem Biophys Res Commun</em>
1989;165:401&#8211;7.</li>

<li class="Ref">Gogu SR, Agrawal KC. The protective role of zinc and N-acetylcysteine in
modulating zidovudine induced hematopoietic toxicity. <em>Life Sci</em>
1996;59:1323&#8211;9.</li>

<li class="Ref">Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme
Q10 in HIV-infection and exploratory treatment. <em>Biochem Biophys Res Commun</em>
1988;153:888&#8211;96.</li>

<li class="Ref">Fabris N, Mocchegiani E, Galli M, et al. AIDS, zinc deficiency, and thymic
hormone failure. <em>JAMA</em> 1988;259:839&#8211;40.</li>

<li class="Ref">Dworkin BM. Selenium deficiency in HIV infection and the acquired
immunodeficiency syndrome (AIDS). <em>Chem Biol Interact</em> 1994;91:181&#8211;6.</li>

<li class="Ref">Mocchegiani E, Veccia S, Ancarani F, et al. Benefit of oral zinc
supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in
AIDS. <em>Int J Immunopharmacol</em> 1995;17:719&#8211;27.</li>

<li class="Ref">Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal
malabsorption in HIV disease. <em>J Pediatr Gastroenterol Nutr</em> 1996;22:359&#8211;63.</li>

<li class="Ref">Humbert JR, Moore LL. Iron deficiency and infection: a dilemma. <em>J Pediatr
Gastroenterol Nutr</em> 1983;2:403&#8211;6.</li>

<li class="Ref">Robinson MK, Hong RW, Wilmore DW. Glutathione deficiency and HIV infection.
<em>Lancet</em> 1992;339:1603&#8211;4.</li>

<li class="Ref">Shabert JK, Wilmore DW. Glutamine deficiency as a cause of human
immunodeficiency virus wasting. <em>Med Hypotheses</em> 1996;46:252&#8211;6.</li>

<li class="Ref">Noyer CM, Simon D, Borczuk A, et al. A double-blind placebo-controlled pilot
study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. <em>Am
J Gastroenterol</em> 1998;93:972&#8211;5 .</li>

<li class="Ref">Shabert JK, Winslow C, Lacey JM, Wilmore DW. Glutamine-antioxidant
supplementation increases body cell mass in AIDS patients with weight loss: a randomized,
double-blind controlled trial. <em>Nutrition</em> 1999;15:860&#8211;4.</li>

<li class="Ref">Muller F, Svardal AM, Aukrust P, et al. Elevated plasma concentration of
reduced homocysteine in patients with human immunodeficiency virus infection. <em>Am J Clin
Nutr</em> 1996;242&#8211;6.</li>

<li class="Ref">Revillard JP. Lipid peroxidation in Human Immunodeficiency Virus infection.
<em>J Acquired Immunodef Synd</em> 1992;5:637&#8211;8.</li>

<li class="Ref">Singer P, Katz DP, Dillon L, et al. Nutritional aspects of the acquired
immunodeficiency syndrome. <em>Am J Gastroenterol</em> 1992;87:265&#8211;73.</li>

<li class="Ref">Tan SV, Guiloff RJ. Hypothesis on the pathogenesis of vacuolar myelopathy,
dementia, and peripheral neuropathy in AIDS. <em>J</em>&nbsp;<em>Neurol Neurosurg
Psychiat</em> 1998;65:23&#8211;8.</li>

<li class="Ref">Keating JN, Trimble KC, Mulcahy F, et al. Evidence of brain methyltransferase
inhibition and early brain involvement in HIV-positive patients. <em>Lancet</em>
1991;337:935&#8211;9.</li>

<li class="Ref">Dorfman D, DiRocco A, Simpson D, et al. Oral methionine may improve
neuropsychological function in patients with AIDS myelopathy: results of an open-label trial.
<em>AIDS</em> 1997;11:1066&#8211;7.</li>

<li class="Ref">Valesini G, Barnaba V, Benvenuto R, et al. A calf thymus lysate improves
clinical symptoms and T-cell defects in the early stages of HIV infection: Second report. <em>
Eur J Cancer Clin Oncol</em> 1987;23:1915&#8211;9.</li>

<li class="Ref">Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey
proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr
2002;41:12&#8211;8.</li>

<li class="Ref">Wong KF, Middleton N, Montgomery M, et al. Immunostimulation of murine spleen
cells by materials associated with bovine milk protein fractions. J Dairy Sci
1998;81:1825&#8211;32.</li>

<li class="Ref">Minehira K, Inoue S, Nonaka M, et al. Effects of dietary protein type on
oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism and
indices of immune function in rats. Biochim Biophys Acta 2000;1483:141&#8211;53.</li>

<li class="Ref">Durant J, Chantre Ph, Gonzalez G, et al. Efficacy and safety of Buxus
sempervirens L. preparations (SPV30) in HIV-infected asymptomatic patients: a multicentre,
randomized, double-blind, placebo-controlled trial. <em>Phytomedicine</em>
1998;5(1):1&#8211;10.</li>

<li class="Ref">Ito M, Sato A, Hirabayashi K, et al. Mechanism of inhibitory effect of
glycyrrhizin on replication of human immunodeficiency virus (HIV). <em>Antivir Res</em>
1988;10:289&#8211;98.</li>

<li class="Ref">Hattori I, Ikematsu S, Koito A, et al. Preliminary evidence for inhibitory
effect of glycyrrhizin on HIV replication in patients with AIDS. <em>Antivir Res</em>
1989;11:255&#8211;62.</li>

<li class="Ref">Ikegami N, Akatani K, Imai M, et al. Prophylactic effect of long-term oral
administration of glycyrrhizin on AIDS development of asymptomatic patients. <em>Int Conf
AIDS</em> 1993;9:234 [abstract PO-A25&#8211;0596].</li>

<li class="Ref">Koch J, Tuveson J, Carlson T, Schmidt J. SB-300: a new and effective therapy
for HIV-associated diarrhea. Poster presented at the Seventh European Conference on Clinical
Aspects and Treatment of HIV-Infection, Lisbon, Portugal, October 23&#8211;27, 1999.</li>

<li class="Ref">Holodniy M, Koch J, Mistal M, et al. A double blind, randomized,
placebo-controlled phase II study to assess the safety and efficacy of orally administered
SP-303 for the symptomatic treatment of diarrhea in patients with AIDS. <em>Am J
Gastroenterol</em> 1999;94:3267&#8211;73.</li>

<li class="Ref">Koch J. A phase III, double-blind, randomized, placebo-controlled multi-center
study of SP-303 (Provir&#8482;) in the symptomatic treatment of diarrhea in patients with
acquired immunodeficiency syndrome (AIDS). Posters presented at the 13th international AIDS
Conference in Durba, South Africa, July 14, 2000.</li>

<li class="Ref">Cooper WC, James J. An observational study of the safety and efficacy of
hypericin in HIV+ subjects. <em>Int Conf AIDS</em> 1990;6:369 [abstract no. 2063].</li>

<li class="Ref">Steinbeck-Klose A, Wernet P. Successful long term treatment over 40 months of
HIV-patients with intravenous hypericin. <em>Int Conf AIDS</em> 1993;9:470 [abstract no.
PO-B26&#8211;2012].</li>

<li class="Ref">Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin,
the active compound in St. John&#8217;s wort, as an antiretroviral agent in HIV-infected
adults. AIDS clinical trial group protocols 150 and 258. <em>Ann Intern Med</em>
1999;130:510&#8211;4.</li>

<li class="Ref">Abdullah TH, Kirkpatrick DV, Carter J. Enhancement of natural killer cell
activity in AIDS with garlic. <em>Dtsch Zschr Onkol</em> 1989;21:52&#8211;3.</li>

<li class="Ref">Shoji S, Furuishi K, Yanase R, et al. Allyl compounds selectively killed human
immunodeficiency virus (type 1)-infected cells. <em>Biochem Biophys Res Commun</em>
1993;194:610&#8211;21.</li>

<li class="Ref">Miller S. Synopsis of PN355 Androvir study. Unpublished study. Seattle: Bastyr
University, 1997.</li>

<li class="Ref">Cho YK, Kim Y, Choi M, et al. The effect of red ginseng and zidovudine on HIV
patients. <em>Int Conf AIDS</em> 1994;10:215 [abstract no. PB0289].</li>

<li class="Ref">Inada Y, Watanabe K, Kamiyama M, et al. In vitro immunomodulatory effects of
traditional Kampo medicine (sho-saiko-to: SST) on peripheral mononuclear cells in patients
with AIDS. <em>Biomed Pharmacother</em> 1990;44:17&#8211;9.</li>

<li class="Ref">Piras G, Makino M, Baba M. Sho-saiko-to, a traditional kampo medicine,
enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro. <em>Microbiol Immunol</em>
1997;41:435&#8211;9.</li>

<li class="Ref">Fujimaki M, Hada M, Ikematsu S, et al. Clinical efficacy of two kinds of kampo
medicine on HIV infected patients. <em>Int Conf AIDS</em> 1989;5:400 [abstract no.
W.B.P.292].</li>

<li class="Ref">Li BQ, Fu T, Yan YD, et al. Inhibition of HIV infection by baicalin&#8212;a
flavonoid compound purified from Chinese herbal medicine. <em>Cell Mol Biol Res</em>
1993;39:119&#8211;24.</li>

<li class="Ref">Yamada Y, Nanba H, Kuroda H. Antitumor effect of orally administered extracts
from fruit body of Grifola frondosa (maitake). <em>Chemotherapy</em> 1990;38:790&#8211;6.</li>

<li class="Ref">Nanba H. Immunostimulant activity in-vivo and anti-HIV activity in vitro of 3
branched b-1&#8211;6-glucans extracted from maitake mushrooms (Grifola frondosa). VIII
International Conference on AIDS, 1992 [abstract].</li>

<li class="Ref">Luettig B, Steinmuller C, Gifford GE, et al. Macrocytic activation by the
polysaccharide arabinogalactan isolated from plant cell cultures of <em>Echinacea
purpurea.</em>&nbsp;<em>J Natl Cancer Inst</em> 1989;81:669&#8211;75.</li>

<li class="Ref">Elsasser-Beile U, Willenbacher W, Bartsch HH, et al. Cytokine production in
leukocyte cultures during therapy with <em>Echinacea</em> extract. <em>J Clin Lab Anal</em>
1996;10:441&#8211;5.</li>

<li class="Ref">Berman S, See DM, See JR, et al. Dramatic increase in immune mediated HIV
killing activity induced by <em>Echinacea angustifolia.</em>&nbsp;<em>Int Conf AIDS</em>
1998;12:582 [abstract no. 32309].</li>

<li class="Ref">Gorter R, Khwaja T, Linder M. Anti-HIV and immunomodulating activities of <em>
Viscum album</em> (mistletoe). <em>Int Conf AIDS</em> 1992;8:84 [abstract no. PuB 7214].</li>

<li class="Ref">Gorter R, Stoss M, el Arif N, et al. Immune modulating and anti-HIV activities
of <em>Viscum album</em> (Iscador). <em>Int Conf AIDS</em> 1993;9:496 [abstract no.
PO-B28&#8211;2167].</li>

<li class="Ref">Copeland R, Baker D, Wilson H. Curcumin therapy in HIV-infected patients. <em>
Int Conf AIDS</em> 1994;10:216 [abstract no. PB0876].</li>

<li class="Ref">Hellinger JA, Cohen CJ, Dugan ME, et al. Phase I/II randomized, open-label
study of oral curcumin safety, and antiviral effects on HIV-RT PCR in HIV+ individuals. <em>
3rd Conf Retro and Opportun Infect</em> 1996;Jan/Feb:78 [abstract].</li>

<li class="Ref">Keplinger UM. Influence of Krallendorn extract on retroviral infection. <em>
Z&#252;rcher AIDS Kongress</em> Zurich, Switzerland, Oct 16&#8211;7, 1992 [abstract in
German].</li>

<li class="Ref">Keplinger UM. Therapy of HIV-infected individuals in the pathological
categories CDC A1 and CDC B2 with a preparation containing IMM-207. IV.
&#214;<em>sterreichischer AIDS-Kongress</em>, Vienna, Austria, Sept 17&#8211;8, 1993, 45
[abstract].</li>

<li class="Ref">Jandourek A, Vaishampayan JK, Vazquez JA. Efficacy of melaleuca oral solution
for the treatment of fluconazole refractory oral candidiasis in AIDS patients. <em>AIDS</em>
1998;12:1033&#8211;7.</li>

<li class="Ref">Standish L, Guiltinan J, McMahon E, Lindstrom C. One year open trial of
naturopathic treatment of HIV infection class IV-A men. <em>J Naturopathic Med</em>
1992;3:42&#8211;64.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/HIV_Support.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:19 GMT -->
</html>

